A multinational RNA-sequencing study of 1,223 B-ALL cases found that ZNF384 fusions confer an intermediate-risk and TCF3::PBX1 a high-risk profile in adult B-ALL patients (37). This evidence concerns the gene TCF3 and precursor B-cell acute lymphoblastic leukemia.